Ricebran technologies (RIBT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues

8,330

5,830

5,300

6,219

6,364

4,549

3,463

3,198

3,552

-

3,445

3,146

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold

8,735

6,431

5,659

6,463

6,021

3,938

2,709

2,535

2,598

-

2,305

2,348

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues, net

-

-

-

-

-

-

-

-

-

-

-

-

3,615

-3,551

3,249

3,233

10,051

9,915

8,917

11,405

9,659

10,670

10,411

11,343

7,684

8,229

8,725

9,388

8,709

8,917

9,349

9,711

9,746

8,402

9,405

10,502

8,648

8,403

7,501

Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

2,428

-2,824

2,434

2,431

7,814

7,191

6,860

9,170

8,605

9,776

9,446

10,147

6,270

7,298

7,955

8,110

7,743

8,225

7,473

7,948

8,005

7,523

7,506

7,915

6,442

6,269

6,029

Gross profit (loss)

-405

-601

-359

-244

343

611

754

663

954

666

1,140

798

1,187

-727

815

802

2,237

2,724

2,057

2,235

1,054

894

965

1,196

1,414

931

770

1,278

966

692

1,876

1,763

1,741

879

1,899

2,587

2,206

2,134

1,472

Selling, general and administrative expenses

2,550

3,098

3,835

3,422

3,341

3,092

2,419

2,830

2,853

2,460

2,495

2,667

2,266

2,189

3,140

3,676

3,379

2,751

2,977

3,352

3,487

3,610

4,014

3,415

3,315

3,892

3,132

2,260

3,082

4,123

2,864

3,058

3,645

3,466

3,734

3,764

3,477

3,929

3,610

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

348

419

426

429

505

607

695

759

818

298

302

318

331

-

-

-

-

-

-

-

-

-

-

Goodwill impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

366

516

471

804

518

798

802

668

507

Impairment of property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

300

0

0

1,069

0

-

0

0

-

0

1,000

Recoveries from former customers

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,000

0

0

-800

0

0

Loss on disposal of property, plant and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-540

-27

Provision for doubtful accounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,727

3,170

3,403

3,781

3,992

4,217

4,709

4,174

4,133

4,190

3,434

2,578

3,713

2,770

3,230

4,643

4,116

4,862

4,252

4,562

3,479

5,137

5,194

Operating loss

-2,955

-3,699

-4,194

-3,666

-2,998

-2,481

-1,665

-2,167

-1,899

-1,794

-1,355

-1,869

-1,079

-2,568

-2,325

-2,874

-1,490

-446

-1,346

-1,546

-2,938

-3,323

-3,744

-2,978

-2,719

-3,259

-2,664

-1,300

-2,747

-2,078

-1,354

-2,880

-2,375

-3,983

-2,353

-1,975

-1,273

-3,003

-3,722

Interest income

11

8

19

23

0

-

0

0

-

-

-

-

-

-

-

-

33

16

23

19

49

15

63

22

15

35

48

16

10

8

3

16

47

21

25

67

13

26

4

Other income (expense):
Interest expense - accreted on debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

292

-

57

130

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense - accreted on debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

208

-

0

6,222

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense - accreted on debt converted to equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Interest expense - other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

799

606

704

745

591

-

1,043

1,202

-

-

1,084

1,024

-

-

-

-

-

-

-

-

-

-

-

Interest expense

49

56

9

19

12

7

2

2

1

7

86

475

1,055

-

352

454

-

-

-

-

-

-

-

-

1,188

-

-

-

629

623

498

387

418

649

302

424

388

416

300

Other expense

45

11

1

3

1

0

12

0

13

-31

113

0

100

-65

0

0

65

-

55

82

75

90

200

111

198

-127

152

223

125

61

59

23

94

14

24

401

25

10

0

Yield payable to holders of noncontrolling interest in Nutra SA

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative warrant liabilities

-

-

-

-

-

-

-

-

-

-138

-313

22

1,099

1,311

1,166

-1,663

811

-210

654

384

173

470

49

-3,786

2,058

889

576

1,044

-3,538

1,412

3,502

2,868

-2,362

-

-

-

-

-

-

Loss on acquisition of controlling interest in Rice Rx

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10

Change in fair value of derivative warrant and conversion liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

916

2,435

-2,576

250

-508

Loss on acquisition of additional interests in Rice Rx

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Loss on extinguishment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Financing expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

950

1,122

0

0

564

0

0

640

20

1,524

0

0

0

0

-

-

Foreign currency exchange, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

66

-90

-93

32

-219

-106

-203

60

75

-94

-58

-538

250

-44

209

-576

-206

169

-321

9

44

-23

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

0

-6,610

0

-1,680

0

0

0

0

-

0

-1,904

-

-

0

-892

-

-2,365

0

-494

-32

0

-1,955

0

-2,986

-

-

-

-

-

-

Loss on conversion of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on resolution of Irgovel purchase litigation

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,598

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

5

19

859

6

0

-

52

9

-

112

157

33

5

-

132

0

-

-

2

8

157

-48

10

4

46

-14

22

2

3

2

18

3

4

-181

46

309

58

54

107

Total other income

-

-

868

7

-

125

38

7

-14

-2

-6,965

-420

-1,731

1,122

946

-2,117

1,352

-1,114

-230

-2,418

-714

-452

-1,324

-13,077

-314

-2,619

-648

-1,781

-4,061

694

580

1,881

-7,539

-1,097

340

1,995

-2,874

-119

-707

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

111

399

Loss before income taxes

-3,033

-3,739

-3,326

-3,659

-3,011

-2,356

-1,627

-2,160

-1,913

-1,796

-8,320

-2,289

-2,810

-1,446

-1,379

-4,991

-138

-1,560

-1,576

-3,964

-3,652

-3,775

-5,068

-16,055

-3,033

-5,878

-3,312

-3,081

-6,808

-1,384

-774

-999

-9,914

-5,080

-2,013

20

-4,147

-3,233

-4,828

Income tax benefit

0

0

0

0

0

45

0

0

0

3

-4,121

-515

-397

-872

-437

-515

0

-158

-6

-6

-6

-567

-139

-350

-248

278

-636

-571

-510

-830

-194

-369

-542

-93

-244

52

-60

-143

-300

Loss from continuing operations

-3,033

-3,739

-3,326

-3,659

-3,011

-2,401

-1,627

-2,160

-1,913

-1,799

-4,199

-1,774

-2,413

-

-942

-4,476

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations

0

0

0

0

-216

0

0

0

0

-2,839

6,706

304

-188

-

-608

-3,640

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-3,033

-3,739

-3,326

-3,659

-3,227

-2,401

-1,627

-2,160

-1,913

-4,638

2,507

-1,470

-2,601

-1,446

-1,550

-8,116

-138

-1,402

-1,570

-3,958

-3,646

-3,208

-4,929

-15,705

-2,785

-6,156

-2,676

-2,510

-6,298

-554

-580

-630

-9,372

-4,987

-1,769

-32

-4,087

-3,090

-4,528

Less - Net loss attributable to noncontrolling interest in discontinued operations

-

-

-

-

-

-

-

-

-

-312

-792

-248

-319

-

-470

-1,508

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to noncontrolling interest in Nutra SA

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-438

-186

-1,046

-432

-644

-800

-1,233

-645

-920

-986

-605

-543

-485

-443

-212

-429

-543

-461

-276

-11

-28

0

0

Net loss attributable to RiceBran Technologies shareholders

-

-

-

-

-

-

-

-

-

-4,326

3,299

-1,222

-2,282

-1,142

-1,080

-6,608

300

-1,216

-524

-3,526

-3,002

-2,408

-3,696

-15,060

-1,865

-5,170

-2,071

-1,967

-5,813

-111

-368

-201

-8,829

-4,526

-1,493

-21

-4,059

-3,090

-4,528

Less - Dividends on preferred stock, beneficial conversion feature

-

-

-

-

-

-

-

-

-

0

0

0

778

0

0

0

551

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividends on preferred stock-beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to RiceBran Technologies common shareholders

-

-

-

-

-

-

-

-

-

-4,326

3,299

-1,222

-3,060

-1,142

-1,080

-6,608

-251

-1,216

-524

-3,526

-3,002

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic loss per common share:
Continuing operations (in dollars per share)

-0.08

-0.11

-0.10

-0.11

-0.10

-0.08

-0.07

-0.11

-0.11

-0.03

-0.38

-0.18

-0.33

-

-0.10

-0.48

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations (in dollars per share)

0.00

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

0.00

-0.28

0.68

0.06

0.01

-

-0.01

-0.24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic loss per common share (in dollars per share)

-0.08

-0.11

-0.10

-0.11

-0.11

-0.08

-0.07

-0.11

-0.11

-0.31

0.30

-0.12

-0.32

-0.11

-0.11

-0.72

-0.03

-0.13

-0.06

-0.38

-0.33

0.65

-0.47

-3.52

-0.62

-3.72

-1.83

-1.83

-5.57

-9.25

0.00

0.00

-0.04

-0.02

-0.01

0.00

-0.02

-0.02

-0.02

Diluted loss per common share:
Continuing operations (in dollars per share)

-0.08

-0.11

-0.10

-0.11

-0.10

-0.08

-0.07

-0.11

-0.11

-0.03

-0.38

-0.18

-0.33

-

-0.10

-0.48

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations (in dollars per share)

0.00

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

0.00

-0.28

0.68

0.06

0.01

-

-0.01

-0.24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted loss per common share (in dollars per share)

-0.08

-0.11

-0.10

-0.11

-0.11

-0.08

-0.07

-0.11

-0.11

-0.31

0.30

-0.12

-0.32

-0.11

-0.11

-0.72

-0.03

-0.13

-0.06

-0.38

-0.33

0.65

-0.47

-3.52

-0.62

-3.72

-1.83

-1.83

-5.57

-9.25

0.00

0.00

-0.04

-0.02

-0.01

0.00

-0.02

-0.02

-0.02

Weighted average number of shares outstanding:
Basic (in shares)

39,963

33,828

33,057

33,204

29,347

26,854

24,092

20,366

17,083

17,113

11,129

9,794

9,657

9,508

9,397

9,231

9,215

9,207

9,222

9,167

9,154

8,030

7,915

4,274

3,017

1,394

1,129

1,073

1,043

-608,050

204,869

204,588

202,686

-198,981,024

199,380,838

198,310

195,358

193

193,028

Diluted (in shares)

39,963

33,828

33,057

33,204

29,347

26,854

24,092

20,366

17,083

17,113

11,129

9,794

9,657

9,508

9,397

9,231

9,215

9,207

9,222

9,167

9,154

8,030

7,915

4,274

3,017

1,394

1,129

1,073

1,043

-608,050

204,869

204,588

202,686

-198,981,024

199,380,838

198,310

195,358

193

193,028